Method for evaluating differentiation state into neural cells

JP7585957B2Active Publication Date: 2024-11-19SHIMADZU SEISAKUSHO LTD
View PDF 3 Cites 0 Cited by

Patent Information

Application Number
JP2021080525
Authority / Receiving Office
JP · JP
Patent Type
Patents
Current Assignee / Owner
Filing Date
2021-05-11
Publication Date
2024-11-19
Estimated Expiration
2041-05-11

AI Technical Summary

Benefits of technology

【0008】 本発明の第1の態様によれば、多能性幹細胞が神経細胞へ分化しているか否かを非侵襲的に評価することができる。

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure 0007585957000001
    Figure 0007585957000001
  • Figure 0007585957000002
    Figure 0007585957000002
  • Figure 0007585957000003
    Figure 0007585957000003
Patent Text Reader

Abstract

To evaluate noninvasively whether a pluripotent stem cell has differentiated into a neuron.SOLUTION: The present invention discloses a method for evaluating the state of differentiation of a cultured pluripotent stem cell into a neuron, when performing a plurality of culture stages to induce the pluripotent stem cell into the neuron. The method includes a measurement step of measuring the abundance of an index substance in a conditioned medium in a plurality of culture stages; and a determination step of determining the differentiation state of the cultured cell on the basis of the abundance of the index substance, where the index substance is at least one of 2-amino ethanol, choline, glutamic acid and serine.SELECTED DRAWING: Figure 4
Need to check novelty before this filing date? Find Prior Art

Description

[Technical field]

[0001] The present invention relates to a method for evaluating the state of differentiation into nerve cells. [Background technology]

[0002] Conventionally, methods such as immunostaining and quantification of the expression level of marker genes have been widely used as methods for evaluating the differentiation state of cells. However, these methods require invasive treatment of cells, and therefore the cells used for the evaluation cannot be used for other purposes, such as as a cell source for regenerative medicine. Therefore, in recent years, methods that do not require invasive treatment of cells have been proposed (see Patent Document 1).

[0003] In the method of evaluating the differentiation state of Patent Document 1, pluripotent stem cells with an unknown differentiation state are used as test cells, and pluripotent stem cells with a known differentiation state are used as control cells, and the amount of kynurenine present in the culture supernatant of the test cells is compared with the amount of kynurenine present in the culture supernatant of the control cells. [Prior art documents] [Patent documents]

[0004] [Patent Document 1] Patent No. 6332440 Summary of the Invention [Problem to be solved by the invention]

[0005] The evaluation method of Patent Document 1 is effective for evaluating whether pluripotent stem cells are in an undifferentiated state or not, but has the drawback that when inducing differentiation of pluripotent stem cells into target cells such as nerve cells, it is not possible to evaluate whether the pluripotent stem cells have differentiated into the target cells or not.

[0006] An object of the present invention is to provide a method for non-invasively evaluating the state of differentiation into neurons when inducing differentiation of pluripotent stem cells into neurons. [Means for solving the problem]

[0007] A first aspect of the present invention is a method for evaluating the differentiation state of cultured cells into neurons when multiple culture steps are performed to induce differentiation of pluripotent stem cells into neurons, the method comprising a measurement step of measuring the amount of an indicator substance present in a culture supernatant during the multiple culture steps, and a determination step of determining the differentiation state of the cultured cells based on the amount of the indicator substance present, wherein the indicator substance is at least one of 2-aminoethanol, choline, glutamic acid, and serine. Effect of the Invention

[0008] According to the first aspect of the present invention, it is possible to non-invasively evaluate whether or not pluripotent stem cells have differentiated into neural cells. [Brief description of the drawings]

[0009] [Figure 1] FIG. 1 is a schematic diagram illustrating a method for evaluating the state of differentiation into nerve cells in a first embodiment of the present invention. [Diagram 2] 1 shows examples of components of the medium (StemFit) used in the Examples. [Diagram 3] 1 shows examples of components of a medium (DMEM / F12) used in an example. [Figure 4] 1 is a graph showing the time course of the amount of an indicator substance (2-aminoethanol) determined by LCMS analysis of a culture supernatant in an example, in which the vertical axis indicates the difference in the area ratio of the indicator substance to the standard substance, and the horizontal axis indicates the number of days of culture. [Diagram 5] 1 is a graph showing the change over time in the amount of an indicator substance (choline) present, determined by LCMS analysis of a culture supernatant in an example. [Figure 6] 1 is a graph showing the change over time in the amount of an indicator substance (glutamic acid) present, determined by LCMS analysis of a culture supernatant in an example. [Figure 7] 1 is a graph showing the change over time in the amount of an indicator substance (serine) present, determined by LCMS analysis of a culture supernatant in an example. [Figure 8] 1 is a graph showing the change over time in the amount of an indicator substance (ornithine) present, determined by LCMS analysis of a culture supernatant in a reference example. [Figure 9] 1 is a graph showing the change over time in the amount of an indicator substance (cystine) present, determined by LCMS analysis of a culture supernatant in a reference example. [Figure 10] 1 is a graph showing the change over time in the amount of an indicator substance (riboflavin) present, determined by LCMS analysis of a culture supernatant in a reference example. DETAILED DESCRIPTION OF THE PREFERRED EMBODIMENTS

[0010] 1. First Aspect The first aspect is a method for evaluating the differentiation state of cultured cells into neurons when multiple culture steps (culture processes) are performed to induce differentiation of pluripotent stem cells into neurons. That is, in the first aspect, the method for evaluating the differentiation state is performed on cells being cultured when multiple culture steps are performed.

[0011] [Culture stage] The first embodiment comprises, in order, a preparatory culture step and a differentiation culture step.

[0012] (Preparatory culture stage) In the preparatory culture stage, pluripotent stem cells are cultured in preparation for differentiation culture according to the purpose, for example, proliferation, acclimatization, etc. The preparatory culture stage includes, in order, a maintenance culture stage and an acclimatization culture stage.

[0013] In the maintenance culture stage (undifferentiated maintenance culture stage), pluripotent stem cells are prepared as cultured cells, and the pluripotent stem cells are grown in an undifferentiated state. Examples of pluripotent stem cells include iPS cells and ES cells. As a culture medium, a medium generally used for culturing pluripotent stem cells may be used, such as the StemFit (registered trademark) series. An example of the components of StemFit is shown in FIG. 2. If necessary, a cell culture substrate such as iMatrix-511 may be coated on the culture vessel to efficiently grow the pluripotent stem cells.

[0014] In the acclimation culture stage, the proliferated pluripotent stem cells are acclimated. Specifically, the cells are made to differentiate into nerve cells. The medium may be, for example, the same medium as that used in the maintenance culture stage. If necessary, the medium may be supplemented with a receptor inhibitor, such as a TGF-β receptor inhibitor, a BMP inhibitor, or a GSK3 inhibitor, for inducing differentiation into nerve cells.

[0015] In the preparatory culture step, either adhesion culture or suspension culture may be performed, and is appropriately determined according to a conventional method depending on the type of pluripotent stem cells or medium, etc. In the first embodiment, for example, adhesion culture may be adopted in both the maintenance culture step and the acclimation culture step.

[0016] (Differentiation culture stage) In the differentiation culture stage, the pluripotent stem cells are induced to differentiate into neural cells. The differentiation culture stage comprises a first differentiation culture stage and a second differentiation culture stage in this order.

[0017] In the first differentiation culture stage, the pluripotent stem cells (cultured cells) after the preparatory culture stage are induced to differentiate into neural progenitor cells. Examples of media used in the first differentiation culture stage include DMEM / F12 and media containing DMEM / F12 as the main component (e.g., mTeSR1). Figure 3 shows an example of the components of DMEM / F12. Additives are added to the medium to induce neural progenitor cells. Examples of additives include sugars, amino acids, buffers, various growth factors, various inhibitors, and various supplements.

[0018] In the second differentiation culture stage, the pluripotent stem cells (cultured cells) after the first differentiation culture stage, i.e., neural progenitor cells, are induced to differentiate into cerebral cortical neurons. The culture used in the second differentiation culture stage can be the same as that used in the first differentiation culture stage. Additives for inducing the cells into cerebral cortical neurons are added to the medium. Examples of additives include sugars, amino acids, buffers, and various supplements. If necessary, a cell culture substrate such as poly-L-ornithine or laminin can be coated on the culture vessel to ensure differentiation into neural cortical neurons.

[0019] In the differentiation culture stage, either adhesion culture or suspension culture may be performed, and is appropriately determined according to a conventional method depending on the type of cultured cells or medium, etc. In the first embodiment, for example, suspension culture may be used in the first differentiation culture stage, and adhesion culture may be used in the second differentiation culture stage.

[0020] In the first embodiment, subculture is performed at each of the above-mentioned culture stages. That is, medium exchange is performed. The medium exchange can be performed by a known method. The medium exchange may be performed, for example, every 1 to 2 days at the preparatory culture stage and every 2 to 4 days at the differentiation culture stage.

[0021] [Evaluation method] The first aspect is an evaluation method comprising a measuring step and a determining step in that order.

[0022] (Measurement step) In the measurement step, the amount of the indicator substance present in the culture supernatant is measured. That is, each time the medium is replaced, the supernatant is obtained for the used medium, and the amount of the indicator substance present in the culture supernatant is measured. Specifically, the amount of the indicator substance present is measured for both (a) the culture supernatant in the medium before use, and (b) the culture supernatant in the medium after the medium has been used in the above-mentioned culture stage. Next, the increase or decrease in the indicator substance before and after use is calculated.

[0023] The indicator substance is at least one of 2-aminoethanol, choline, glutamic acid, and serine.

[0024] At each culture step, the amount of the indicator substance present in at least one medium should be measured, but preferably, more than half of the medium used, and more preferably, all of the medium used should be measured.

[0025] As a method for measuring the amount of the indicator substance in the culture supernatant, for example, quantitative analysis by mass spectrometry, particularly quantitative analysis using a liquid chromatography mass spectrometer (LC-MS) or a gas chromatography mass spectrometer (GC-MS) can be suitably used. Other methods include, for example, a method in which the culture supernatant is injected together with an eluent into a liquid chromatography device and the eluted components are detected with a spectroscopic detector (for example, an ultraviolet-visible spectroscopic detector, an infrared spectroscopic detector); a method in which a reagent that specifically causes the indicator substance to emit light is added to the culture supernatant and the luminescence intensity is detected, and the like.

[0026] The amount of the indicator substance may be measured by measuring the absolute amount or the relative amount. For example, when measuring the relative amount by mass spectrometry, a predetermined amount of a standard substance (e.g., isopropylmalic acid) is added to a sample containing the indicator substance, mass spectrometry is performed, and a relative value is calculated by standardizing the measurement result of the indicator substance (area of ​​mass chromatogram) with the measurement result of the standard substance. Then, the relative value may be determined as the amount of the indicator substance in the determination step.

[0027] (Decision step) In the determination step, the differentiation state of the cultured cells is determined based on the amount of the indicator substance present. Specifically, the change over time in the amount of the indicator substance present (more specifically, the increase or decrease in the amount of the indicator substance) measured at each culture stage is confirmed. In particular, the tendency of the increase or decrease in the amount of the indicator substance before and after use of the culture medium changes between the preparatory culture stage and the differentiation culture stage.

[0028] For example, when the indicator substance is 2-aminoethanol, the amount of 2-aminoethanol present during the preparatory culture stage tends to decrease overall. That is, the amount of 2-aminoethanol present during the culture medium tends to be consumed. On the other hand, during the differentiation culture stage, the amount of 2-aminoethanol present during the differentiation culture stage tends to remain almost constant overall.

[0029] When the indicator substance is choline, the amount of choline present generally tends to decrease during the preparatory culture stage, whereas the amount of choline generally tends to increase during the differentiation culture stage, i.e., choline tends to be produced.

[0030] When the indicator substance is glutamic acid, the amount of glutamic acid present generally tends to increase during the preparatory culture stage, whereas the amount of glutamic acid present generally tends to decrease during the differentiation culture stage.

[0031] The indicator substance is parsley In In some cases, during the preparatory culture stage, Serine The abundance of tends to decrease overall. On the other hand, during the differentiation culture stage, Serine The abundance of these species shows an overall tendency to increase.

[0032] In addition, each stage may be compared in two stages: a preparatory culture stage and a differentiation culture stage, or in four stages: a maintenance culture stage, an acclimation culture stage, a first differentiation culture stage, and a second differentiation culture stage.

[0033] The tendency of increase or decrease of the indicator substance may be determined by the average value for each stage, or may be determined by the greater number of increases or decreases for each stage. That is, if, for example, 10 culture media are used in the preparatory culture stage, the tendency of increase or decrease may be determined by the average value of the 10 increases or decreases. Also, the tendency of increase or decrease may be determined by classifying each of the 10 culture media into "increase," "constant," or "decrease," and adopting the most common classification.

[0034] The classification of increase, constant, and decrease may be, for example, a constant range of increase or decrease within a predetermined threshold, and an increase or decrease range beyond the threshold. The threshold may be appropriately set in view of the degree of increase or decrease of the indicator substance before and after use, the amount of the standard substance added, etc.

[0035] The measurement of each culture supernatant may be performed immediately after collection of the culture supernatant, or the collected culture supernatant may be temporarily frozen and stored, and then the measurement may be performed after all the culture supernatants have been collected.

[0036] The first aspect of the present invention allows non-invasive evaluation of whether pluripotent stem cells have differentiated into nerve cells (particularly, neural precursor cells or cerebral cortical neurons). That is, since the culture supernatant is measured, not the cultured cells (pluripotent stem cells or nerve cells induced to differentiate therefrom), there is no need to subject the cultured cells to invasive treatment, and the cells after culture can be used for other purposes. In addition, the evaluation method is easy because the state of differentiation into nerve cells can be determined simply by measuring the amount of 2-aminoethanol, choline, glutamic acid, or serine present in the culture supernatant. In addition, in the first aspect, the measurement can be performed in both adhesion culture and suspension culture, so the state of differentiation can be evaluated without being limited by the culture form.

[0037] 2. Second Aspect In the first embodiment, the preparatory culture stage includes a maintenance culture stage and an acclimation culture stage, but in the second embodiment, for example, the acclimation culture stage may not be included. That is, in the second embodiment, the culture stage includes a maintenance culture stage, a first differentiation culture stage, and a second differentiation culture stage in this order. From the viewpoint of ensuring induction of differentiation into nerve cells, the first embodiment is preferred.

[0038] 3. Aspects It will be appreciated by those skilled in the art that the exemplary embodiments described above are examples of the following aspects.

[0039] (Item 1) A method for evaluating the differentiation state of cultured cells into neurons when inducing differentiation of pluripotent stem cells into neurons by performing multiple culture steps, the method comprising: a measurement step of measuring the amount of an indicator substance present in a culture supernatant during the multiple culture steps; and a determination step of determining the differentiation state of the cultured cells based on the amount of the indicator substance present, wherein the indicator substance may be at least one of 2-aminoethanol, choline, glutamic acid, and serine.

[0040] (Item 2) In the evaluation method according to item 1, the determination step may determine the differentiation state of the cultured cells by confirming a change over time in the amount of the indicator substance present.

[0041] (Item 3) In the evaluation method described in item 1 or 2, the multiple culture steps may sequentially include a differentiation culture step in which the pluripotent stem cells are induced to differentiate into neural cells, and a preparatory culture step in which the pluripotent stem cells are cultured prior to the differentiation culture step, and the differentiation state of the cultured cells may be determined by comparing the amount of the indicator substance measured in the preparatory culture step with the amount of the indicator substance measured in the differentiation culture step.

[0042] (Item 4) In the evaluation method described in item 3, the preparatory culture step may include, in order, a maintenance culture step in which the pluripotent stem cells are proliferated in an undifferentiated state, and an acclimation culture step in which the pluripotent stem cells are acclimated.

[0043] (Item 5) In the evaluation method described in Item 3 or 4, the differentiation culture step may include, in order, a first differentiation culture step for inducing the cells into neural progenitor cells and a second differentiation culture step for inducing the cells into cerebral cortical neurons.

[0044] (Item 6) In the evaluation method according to any one of Items 1 to 5, the indicator substance may be 2-aminoethanol.

[0045] (Item 7) In the evaluation method according to any one of Items 1 to 5, the indicator substance may be at least one of choline and serine.

[0046] (Item 8) In the evaluation method according to any one of Items 1 to 5, the indicator substance may be glutamic acid. EXAMPLES

[0047] The present invention will now be described in detail with reference to examples and comparative examples, but the scope of the present invention is not limited thereto.

[0048] <Cultivation stage> The iPS cells were induced to differentiate into cerebral cortical neurons as shown in the following steps (see Figure 1). For convenience, the day when the maintenance culture was performed was designated as "day minus 14" and the day when the first differentiation culture was performed was designated as "day 0".

[0049] (Maintenance culture stage) iPS cells were established by introducing episomal vectors pCE-HoCT3 / 4, pCE-mp53DD, pCE-hSK, pCE-hUL, and pCXB-EBNA1 into human peripheral blood mononuclear cells.

[0050] Next, StemFit AK02N medium was added to a culture vessel coated with iMatrix-511 (cell culture substrate). The established iPS cells were subcultured using this culture vessel.

[0051] (Acclimatization culture stage) Next, SB431532 (TGF-β inhibitor), LDN193189 (BMP inhibitor), and CHIR99021 (GSK3 inhibitor) were added to the StemFit AK02N medium. The iPS cells were subcultured using this medium.

[0052] (First differentiation culture stage) Next, DMEM / F12 medium was added to the low-adhesion culture vessel, followed by the addition of sugars, amino acids, buffer, FGF2 (fibroblast growth factor), LIF (leukemia inhibitory factor), SB431542, IWP2 (Wnt signal inhibitor), N2 supplement and B27 supplement. Using this culture vessel, the iPS cells were cultured by suspension culture. This resulted in the production of neurospheres, which are neural precursor cells.

[0053] (Second differentiation culture stage) Next, the neurospheres were subcultured in a culture vessel coated with a cell culture substrate containing poly-L-ornithine and laminin, supplemented with DMEM / F12 medium, sugars, amino acids, a buffer, N2 supplement, and B27 supplement, and were then induced to differentiate into cerebral cortical neurons.

[0054] In the maintenance culture and acclimation culture, the medium was changed every 1-2 days until the cell coverage area reached 70-80% of the culture vessel (subconfluent), and the cells were subcultured and transferred to the next culture stage (these two processes are collectively called passaging). In the first differentiation culture, the medium was changed every 2-4 days, and the cells were subcultured to the second differentiation induction on the 12th day. In the second differentiation induction, the medium was changed every 2-3 days, and the cells were cultured until the 26th day. For the passaging, a cell detachment solution containing 1 mM ethylenediaminetetraacetic acid (product name: TrypLE Select, Thermo Fisher Scientific) was used.

[0055] <Evaluation steps> At each medium change, the difference in the area ratio of the mass chromatogram was measured as the increase or decrease in the amount of the indicator substance in the culture supernatant used, according to the LC-MS analysis method described below.

[0056] Example 1: LC-MS analysis of 2-aminoethanol 1. The supernatant of the medium before use in the culture was collected and used as a sample. 20 μL of 0.5 mM isopropyl malic acid solution as an internal standard substance was added to 100 μL of the sample, mixed, and then 200 μL of acetonitrile was added to remove protein. The sample was then centrifuged (15,000 rpm, room temperature, 15 minutes) to collect the supernatant, which was then diluted 10 times with ultrapure water (Milli-Q (registered trademark) water, Merck Ltd.) and subjected to LC-MS analysis. In the LC-MS analysis, the analysis conditions recorded in Shimadzu Corporation's "LC / MS / MS Method Package Cell Culture Profiling" (hereinafter abbreviated as "MP"). MP is a collection of analysis condition parameters for analyzing compounds contained in the medium and metabolites secreted from cells by LC-MS. Compounds were identified based on the following criteria: the difference between the retention time of the standard registered in the MP and the retention time of the compound in the sample is within ±0.3 minutes, both peaks of the quantitative ion and the confirmation ion are detected, and the intensity value is 1000 or more. The compounds were quantified by calculating the peak area of ​​a mass chromatogram for ions (quantitative ions) characteristic of each compound in the sample.

[0057] In the mass chromatogram obtained by the above measurement, the peak area (A) corresponding to 2-aminoethanol was divided by the peak area (B) corresponding to isopropylmalic acid (A / B), and the amount of 2-aminoethanol present before use (C) was calculated.

[0058] 2. The supernatant of the culture medium after use was collected as a sample, and the amount of 2-aminoethanol present after use (D) was calculated in the same manner as in 1 above.

[0059] 3. The amount of 2-aminoethanol present after use (D) was subtracted by the amount of 2-aminoethanol present before use (C) to calculate the increase or decrease in the amount present before and after use (DC). The results are shown in Figure 4.

[0060] (Examples 2 to 4: LC-MS analysis of choline, glutamic acid and serine) The increase or decrease in the amount of choline, glutamic acid, and serine before and after use was calculated in the same manner as in Example 1. The results are shown in Figure 5 (Example 2: choline), Figure 6 (Example 3: glutamic acid), and Figure 7 (Example 4: serine).

[0061] (Reference Example 1: LC-MS analysis of substances other than indicator substances) As examples of indicator substances other than the above, the increase or decrease in the amount of ornithine, cystine, and riboflavin before and after their use was calculated in the same manner as in Example 1. The results are shown in Figure 8 (ornithine), Figure 9 (cystine), and Figure 10 (riboflavin).

[0062] <Confirmation of differentiation induction> At each medium change, a portion of the cells used for culture was separated. mRNA was extracted from the separated cells, and cDNA was synthesized using reverse transcriptase. FOXG1 (a gene marker expressed in telencephalic progenitor cells), MAP2 (a gene marker expressed in myelin lineage cells), and CTIP2 (a gene marker expressed in the cerebral cortex) were measured using a real-time PCR device.

[0063] In addition, immunofluorescence staining targeting the neuronal marker NeuN and the cerebral lipid marker Tbr1 was performed on the cells after differentiation induction culture.

[0064] These results confirmed that there was no differentiation during the maintenance culture and acclimation culture stages, that they were induced to differentiate into neural progenitor cells during the first differentiation stage, and that they were induced to differentiate into cortical neurons during the second differentiation stage.

[0065] <Consideration> As can be seen from Figure 4, 2-aminoethanol tended to decrease (be consumed) in the culture supernatant before day 0 (i.e., the preparatory culture stage), but in the culture supernatant after day 0 (i.e., the differentiation culture stage), the increase or decrease was within 0.05 and remained constant. This shows that 2-aminoethanol is effective as an indicator substance for nerve cells, as the tendency of increase or decrease changes when differentiation induction into nerve cells begins.

[0066] As shown in Figures 5 and 7, choline and serine tended to decrease in the culture supernatant before day 0, but tended to increase (produce) in the culture supernatant after day 0. This shows that choline and serine are effective as indicator substances for nerve cells, since the increase / decrease tendency changes when differentiation induction into nerve cells begins.

[0067] As can be seen from Figure 6, glutamic acid tended to increase in the culture supernatant before day 0, but tended to decrease in the culture supernatant after day 0. This shows that glutamic acid is effective as an indicator substance for nerve cells, as its tendency to increase or decrease changes when differentiation induction into nerve cells begins.

[0068] As shown in Figure 8, ornithine tended to increase in the culture supernatant before day 0, and also in the culture supernatant after day 0. This shows that ornithine is not effective as an indicator substance for nerve cells, because the increase / decrease tendency does not change once differentiation induction into nerve cells begins.

[0069] As shown in Figure 9, cystine showed a tendency to decrease in the culture supernatant before day 0, and also in the culture supernatant after day 0. This shows that cystine is not effective as an indicator substance for nerve cells, because the tendency of increase and decrease does not change once differentiation induction into nerve cells begins.

[0070] As shown in Figure 10, riboflavin showed a constant tendency in the culture supernatant before day 0, and also in the culture supernatant after day 0. This shows that riboflavin is not effective as an indicator substance for nerve cells, because the tendency of increase and decrease does not change once differentiation induction into nerve cells begins.

Claims

1. A method for evaluating a differentiation state of cultured cells into neural cells when inducing differentiation of pluripotent stem cells into neural cells by performing multiple culture steps, comprising: a measuring step of measuring the amount of an indicator substance present in the culture supernatant during the multiple culture steps; a determination step of determining a differentiation state of the cultured cells based on the amount of the indicator substance present; Equipped with the indicator substance is at least one of 2-aminoethanol, choline, and glutamic acid; The plurality of culture steps include A differentiation culture step of inducing differentiation of the pluripotent stem cells into neural cells; a preparatory culture step of culturing the pluripotent stem cells prior to the differentiation culture step; Equipped with the determination step is a step of determining a differentiation state of the cultured cells by comparing the amount of the indicator substance measured in the preparatory culture step with the amount of the indicator substance measured in the differentiation culture step; In the determination step, when the indicator substance is 2-aminoethanol, if the amount of 2-aminoethanol present during the preparatory culture stage shows a tendency to decrease overall, and the amount of 2-aminoethanol present during the differentiation culture stage shows a tendency to remain generally constant, the pluripotent stem cells are determined to have been induced to differentiate into neural cells; When the indicator substance is choline, if the amount of choline present during the preparatory culture stage shows a tendency to decrease overall, and if the amount of choline present during the differentiation culture stage shows a tendency to increase overall, it is determined that the pluripotent stem cells have been induced to differentiate into neural cells; A method for evaluating the differentiation state into neurons, in which, when the indicator substance is glutamic acid, the pluripotent stem cells are determined to have been induced to differentiate into neurons if the amount of glutamic acid present shows an overall tendency to increase during the preparatory culture stage and an overall tendency to decrease during the differentiation culture stage.

2. The evaluation method according to claim 1 , wherein in the determining step, the differentiation state of the cultured cells is determined by confirming a change over time in the amount of the indicator substance present.

3. The preparatory culture step comprises: A maintenance culture step of proliferating the pluripotent stem cells in an undifferentiated state; a conditioning culture step of conditioning the pluripotent stem cells; The method of claim 1 , further comprising, in order:

4. The differentiation culture step comprises: A first differentiation culture step for inducing the cells into neural progenitor cells; A second differentiation culture step for inducing cerebral cortical neurons; The method of claim 1 , further comprising, in order:

5. The evaluation method according to any one of claims 1 to 4, wherein the indicator substance is 2-aminoethanol.

6. The evaluation method according to any one of claims 1 to 4, wherein the indicator substance is choline.

7. The evaluation method according to any one of claims 1 to 4, wherein the indicator substance is glutamic acid.

Citation Information

Patent Citations

  • Apparatus for aligning head and tail of fish body

    JP1988032440A

  • Method for evaluating state of differentiation of cells

    JP2018121659A

  • Evaluation method for differentiation state of cells

    WO2017068801A1